• Dollar firmer into US retail sales
  • US retail sales: key will be Delta’s hit on core
  • RBNZ rate hike odds go up post-GDP
  • Markets ignore a bad Aussie jobs report
  • Minor Canadian releases on tap
  • Global COVID-19 new case trends


Broad dollar strength is coinciding with mixed moves across other global asset classes. 10s are slightly cheaper in the US, Canada and UK but flat to a touch dearer across EGBs. N.A. equity futures are a touch weaker, while European cash markets are up by ½% to over 1% and following a generally weaker Asian overnight session.

Australia’s jobs report was worse than expected all around, but largely anticipated by markets that have grown accustomed to the impact of lockdowns. The A$’s depreciation to the dollar made it a middle-of-the-pack performer against other crosses while the yield curve steepened with longer yields up by about 5–6bps. 146k jobs were lost with a roughly even full-time part-time split. Hours worked fell 3.7% m/m. The participation rate fell 0.8% to 65.2% which drover a down tick in the unemployment rate to 4.5% as more people exited the workforce than lost their jobs.

New Zealand’s Q2 GDP was another statistical footnote as the beat predates the lockdowns that arrived on August 16th. Q2 growth was 2.8% (1.1% consensus). Still, markets viewed pre-lockdown momentum as fanning higher odds of an RBNZ hike at the October 5th meeting and so the curve flattened with 2s up 7bps and 10s up 4bps while the NZ$ is a top performer. The RBNZ was pretty clear the last time that they would have hiked on August 17th only if not for the prior night’s single COVID-19 case that sparked lockdowns. A temporary modest spike in new cases peaked by early September and has since fallen sharply.


The main focus this morning will be upon the state of the US consumer. US retail sales (8:30amET) are expected to drop (consensus -0.7% m/m, Scotia -1.2%) and I think there is more downside than upside to my estimate. Auto sales tanked last month and the Delta effect plus product shortages likely hit sales ex-autos. I still think that choppy data doesn’t throw out the trend in favour of a solid consumer outlook given very healthy finances but rolling waves of COVID-19 variants create noisy data while damaged supply chains have consumers willing to spend but often unable to find product.

The Philly Fed’s business gauge (8:30amET) will be watched to see if it builds upon today’s Empire beat on the path to the next ISM-manufacturing reading. Weekly jobless claims are edging toward the nonfarm reference period for September around pandemic lows (8:30amET).

Canadian data doesn’t matter with just housing starts for August (8:15amET) and a likely drop in wholesale trade (8:30amET) on tap.


See the next two pages for a sweep through global COVID-19 new case trends including Canadian provinces. Brief observations include the following:

  • Canada: Cases continue to climb but so far remain at a pace equal to about one-fourth of the US rise. The largest provinces are all in upswings but new case counts per capita remain low in Quebec and Ontario and are much higher in the western part of the country and especially Alberta and Saskatchewan.
  • US: Cases may be plateauing particularly as they decline in the South and West census regions.
  • Latin America: Cases continue to push lower across all major countries.
  • Europe: UK cases remain elevated while the rest of Europe has seen declines or maintained low readings.
  • Asia-Pacific: Cases are falling in Japan, Thailand and Malaysia (albeit very high in Malaysia), still low in India, exceptionally low in NZ, but Singapore, Australia and Philippines continue to trend upward.
  • Middle East: Israel’s new case trend continues to reach for the sky with the highest per capita rate of any country shown in the collection of global charts.



This report has been prepared by Scotiabank Economics as a resource for the clients of Scotiabank. Opinions, estimates and projections contained herein are our own as of the date hereof and are subject to change without notice. The information and opinions contained herein have been compiled or arrived at from sources believed reliable but no representation or warranty, express or implied, is made as to their accuracy or completeness. Neither Scotiabank nor any of its officers, directors, partners, employees or affiliates accepts any liability whatsoever for any direct or consequential loss arising from any use of this report or its contents.

These reports are provided to you for informational purposes only. This report is not, and is not constructed as, an offer to sell or solicitation of any offer to buy any financial instrument, nor shall this report be construed as an opinion as to whether you should enter into any swap or trading strategy involving a swap or any other transaction. The information contained in this report is not intended to be, and does not constitute, a recommendation of a swap or trading strategy involving a swap within the meaning of U.S. Commodity Futures Trading Commission Regulation 23.434 and Appendix A thereto. This material is not intended to be individually tailored to your needs or characteristics and should not be viewed as a “call to action” or suggestion that you enter into a swap or trading strategy involving a swap or any other transaction. Scotiabank may engage in transactions in a manner inconsistent with the views discussed this report and may have positions, or be in the process of acquiring or disposing of positions, referred to in this report.

Scotiabank, its affiliates and any of their respective officers, directors and employees may from time to time take positions in currencies, act as managers, co-managers or underwriters of a public offering or act as principals or agents, deal in, own or act as market makers or advisors, brokers or commercial and/or investment bankers in relation to securities or related derivatives. As a result of these actions, Scotiabank may receive remuneration. All Scotiabank products and services are subject to the terms of applicable agreements and local regulations. Officers, directors and employees of Scotiabank and its affiliates may serve as directors of corporations.

Any securities discussed in this report may not be suitable for all investors. Scotiabank recommends that investors independently evaluate any issuer and security discussed in this report, and consult with any advisors they deem necessary prior to making any investment.

This report and all information, opinions and conclusions contained in it are protected by copyright. This information may not be reproduced without the prior express written consent of Scotiabank.

™ Trademark of The Bank of Nova Scotia. Used under license, where applicable.

Scotiabank, together with “Global Banking and Markets”, is a marketing name for the global corporate and investment banking and capital markets businesses of The Bank of Nova Scotia and certain of its affiliates in the countries where they operate, including; Scotiabank Europe plc; Scotiabank (Ireland) Designated Activity Company; Scotiabank Inverlat S.A., Institución de Banca Múltiple, Grupo Financiero Scotiabank Inverlat, Scotia Inverlat Casa de Bolsa, S.A. de C.V., Grupo Financiero Scotiabank Inverlat, Scotia Inverlat Derivados S.A. de C.V. – all members of the Scotiabank group and authorized users of the Scotiabank mark. The Bank of Nova Scotia is incorporated in Canada with limited liability and is authorised and regulated by the Office of the Superintendent of Financial Institutions Canada. The Bank of Nova Scotia is authorized by the UK Prudential Regulation Authority and is subject to regulation by the UK Financial Conduct Authority and limited regulation by the UK Prudential Regulation Authority. Details about the extent of The Bank of Nova Scotia's regulation by the UK Prudential Regulation Authority are available from us on request. Scotiabank Europe plc is authorized by the UK Prudential Regulation Authority and regulated by the UK Financial Conduct Authority and the UK Prudential Regulation Authority.

Scotiabank Inverlat, S.A., Scotia Inverlat Casa de Bolsa, S.A. de C.V, Grupo Financiero Scotiabank Inverlat, and Scotia Inverlat Derivados, S.A. de C.V., are each authorized and regulated by the Mexican financial authorities.

Not all products and services are offered in all jurisdictions. Services described are available in jurisdictions where permitted by law.